Scottsdale Weight Loss Center: Primack Craig MD

Scottsdale Weight Loss Center, led by Dr. Craig Primack, MD, FACP, FAAP, MFOMA, provides medical weight loss treatment in Scottsdale, Arizona, with a focus on evidence-based pharmacotherapy including GLP-1 receptor agonist peptides. Dr. Primack holds board certifications from the American Board of Obesity Medicine, American Board of Internal Medicine, and American Board of Pediatrics, bringing multi-specialty training to weight management. His fellowship training in obesity medicine (MFOMA) positions the clinic to address weight loss through a medical lens rather than purely dietary approaches, recognizing obesity as a chronic disease requiring clinical intervention.

The clinic's peptide therapy program centers on semaglutide and tirzepatide, two GLP-1 medications that work by mimicking incretin hormones to regulate appetite, slow gastric emptying, and improve glycemic control. Semaglutide, a once-weekly subcutaneous injection, has demonstrated significant weight reduction in clinical trials by activating GLP-1 receptors in the brain's appetite centers. Tirzepatide functions as a dual GLP-1 and GIP receptor agonist, offering an additional mechanism through glucose-dependent insulinotropic polypeptide pathways. Dr. Primack's protocols involve careful patient selection, dose titration schedules that minimize gastrointestinal side effects, and ongoing monitoring of metabolic markers throughout treatment. Patients receive instruction on proper injection technique, refrigeration requirements, and recognition of potential adverse effects including nausea, constipation, or pancreatitis symptoms.

Dr. Primack's triple board certification allows him to evaluate weight loss candidates through internal medicine, pediatric, and obesity medicine frameworks. His American Board of Obesity Medicine certification requires demonstrated expertise in the pathophysiology of obesity, pharmacologic interventions, behavioral modification strategies, and management of weight-related comorbidities such as type 2 diabetes, hypertension, and sleep apnea. This background enables comprehensive assessment of how excess weight interacts with other medical conditions and medication regimens. The clinic's approach includes laboratory evaluation of thyroid function, insulin resistance markers, lipid panels, and liver enzymes before initiating peptide therapy, ensuring patients are appropriate candidates and establishing baseline values for comparison during treatment.

Patients at Scottsdale Weight Loss Center attend in-person consultations at the Scottsdale location, where Dr. Primack conducts initial evaluations that include medical history review, physical examination, body composition analysis, and discussion of realistic weight loss goals. Follow-up appointments track progress through weight measurements, side effect assessment, and adjustment of peptide dosing as needed. The clinic provides education on nutrition strategies that complement GLP-1 therapy, emphasizing protein intake to preserve lean muscle mass during caloric restriction and hydration protocols to manage common medication side effects. Patients learn to distinguish between normal appetite suppression and concerning symptoms requiring medical attention, with clear protocols for contacting the clinic between scheduled visits.

Serving the Scottsdale, Arizona community, the clinic operates exclusively through in-person visits, allowing Dr. Primack to perform hands-on assessments and build continuity of care with patients throughout their weight loss journey. The practice's focus on medical weight loss through peptide therapy reflects current obesity medicine standards recognizing pharmacotherapy as a legitimate long-term treatment option for patients with BMI over 30 or BMI over 27 with weight-related complications. Dr. Primack's fellowship training in obesity medicine and multiple board certifications provide patients access to a physician specifically trained in the complexities of weight management beyond general primary care scope.